Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Ann Neurol. 2014 Mar;75(3):411–428. doi: 10.1002/ana.24117

Table 3.

Clinical characteristics of the patients with anti-NMDAR encephalitis occurring simultaneously with multifocal or extensive FLAIR-T2 abnormalities

No Age, sex (Ethnicity) Clinical features Atypical features mRS max Immunotherapy NMDAR ab (CSF / serum) AQP4 ab (CSF / serum) MOG ab (CSF / serum) MRI brain / spinal cord CSF: WBC per μl / OCB FU Last mRS
13# 37, F (J) fluctuating level of consciousness, change of behavior bilateral facial & bulbar palsy 5 st, PLEX, IVIG, su + / − >2 / 80 − / − periventricular (3th and 4th ventricle) increased FLAIR abnormalities 76 /− 30 3
14 32, F (C) psychiatric symptoms, depression, irritability, apathy, behavioral changes, attention and language deficit, dysphasia and mild distal myoclonus gait disturbance 4 Unknown + / n.d. − / 20 − / − multiple increased T2 signals in cerebellar peduncles, pons, mid brain, pyramidal tracts, thalamus, internal capsules, and lenticular nuclei, with 2 small periventricular areas of Gd-enhancement / increased T2 signals < 5 / + 20 n.d.
15 16, F (C) headache, diplopia, anisocoria, vertigo, ataxia, intention tremor, memory deficit, anxiety, depression, insomnia; later hemihypesthesia, dyskinesias, and dysarthria; afterwards hemiballismus, hemiparesis, vomiting and flushing diplopia, anisocoria, ataxia, vertigo, vomitus; later hemihypestesia, hemiparesis,-ballismus 4 st, IVIG + / − − / 20 − / − Multiple increased T2/FLAIR signals in the right mesotemporal lobe, cerebellum and thalamus / normal 5 / − 4 4
16* 32, F (C) memory and behavioral dysfunction, depression - 4 1. st, IVIG; 2. st, CTX + / + − / 40 − / − Increased FLAIR signal in hippocampi and caudate nuclei < 5 / + 48 0
17 47, F (J) speech disturbance, behavioral change, orofacial dyskinesias, decreased level of consciousness, seizures, tachycardia and hypoventilation - 5 st, PLEX, IVIG, CTX, RTX + / + n.d. / 20 − / − Multifocal periventricular, subcortical white matter T2/FLAIR increased signal 25 / n.d. 22 1
18 4, F(H) seizures, hemiparesis; later: mutism, chorea, orofacial dyskinesias Hemiparesis 5 st, IVIG + / n.d. n.d. / − 2 / 1280 Multifocal areas of T2/FLAIR increased signal: periventricular, basal ganglia, cerebellum, and pons < 5 / + 7 2
19 6, M (H) irritability, personality change, hypersomnia ataxia, hyperreflexia, Babinski reflexes 5 IVIG + / − n.d. / − >5 / 2560 Multifocal areas of increased FLAIR signal: cortex, subcortex, thalamus, basal ganglia, cerebellum, brainstem, cervical, thoracic cord, with small areas of Gd-enhancement 43 / + 2.5 1
20 13, F(H) confusion, behavioral dysfunction, stupor, orofacial dyskinesias (between DSE 3 and 4) Leg cramps 5 st, IVIG, RTX + / + n.d. / − − / − Multiple subcortical and periventricular T2/FLAIR increased signal abnormalities 18 / − 16 0
21 18, F (C) behavioral and speech dysfunction, orofacial dyskinesias, intubated 9 months before encephalitis: hypesthesia in the legs 5 st, IVIG; RTX, CTX, MMF + / + n.d. / − n.d. / − Single area of `demyelination' in the right frontal region (discovered 2 months before onset encephalitis) 40 / + 34 0
22 19, M (C) seizures, fever (multiple episodes) Oculogyric crises 5 st, AZA + / n.a. − / n.a. − / n.a. Recurrent left parietal T2/FLAIR abnormality with Gd-enhancement 36 / + 36 0
23 62, F (C) seizures, dysarthria, hemiparesis - 4 1. st, IVIG, PLEX, CTX; 2. st, CTX, RTX + / n.a. − / n.a. − / n.a. Extensive areas of increased T2/FLAIR signal in temporal and frontal lobes 88 / n.d. 24 3

Titers for AQP4 and MOG are based on the cell-based assay and provided as the reciprocal number of the highest sample dilution where reactivity was visible.

#

had an ovarian teratoma.

*

also suffered from discoid lupus; developed an identical relapse 15 months later.

has two sisters with relapsing remitting multiple sclerosis.

had a purely psychiatric relapse 10 months later.

mRS modified Rankin Scale; max maximum; AQP4 aquaporin-4; ab antibodies; CSF cerebrospinal fluid; WBC white blood cells; OCB oligoclonal bands; FU follow-up; mo months; F female; M male; J Japanese; C Caucasian; H Hispanic; st steroids; PLEX plasma exchange; IVIG intravenous immunoglobulins; su surgery; CTX cyclophosphamide; RTX rituximab; MMF mycophenolate mofetil; AZA azathioprine; FLAIR fluid attenuation inversion recovery; Gd gadolinium; n.d. not determined.